Posted inCampaigning Community News International Medicines News PrEP Prevention Research Treatment Gilead to support generic lenacapavir in low-income nations Posted by By Tom Hayes-Isaacs 2024-10-08 Earlier this month, Gilead Sciences announced that it had signed non-exclusive, royalty-free voluntary licensing agreements…
Posted inCampaigning International News Prevention Activists demand global access to HIV prevention drug Posted by By Tom Hayes-Isaacs 2024-09-24 HIV and sexual health activists protested today at Gilead Sciences' London Office demanding the company…
Posted inCampaigning Criminalisation Human Rights News Man living with HIV, caught in a Grindr sting, freed from Qatar Posted by By Tom Hayes-Isaacs 2024-08-14 Manuel Guerrero AviƱa, a British-Mexican man living with HIV, who was arrested in a Grindr…
Posted inCampaigning Community News News Social Media Social media lights up for #ZeroStigmaDay Posted by By Tom Hayes-Isaacs 2024-07-23 Sunday 21st July 2024 was #ZeroStigmaDay and all around the world people living with, affected…